Elliot Norry, Chief Medical Officer at Adaptimmune Therapeutics PLC (ADAP), sold 11,292 shares at $1.71 ($19K) on 2023-01-12, disclosed to the SEC on 2023-01-12.
Seasonal sale ($19k) by Chief Medical Officer — this insider has traded ADAP in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.75 | 3,843 | $7K | 34.6% |
| 2 | $1.71 | 7,449 | $13K | 65.4% |
| Total | $1.72 avg | 11,292 | $19K | 100% |
| Filing → |
| ADAP | SELL | 2024-01-17 | $14K | — | Filing → |
| ADAP | SELL | 2024-01-12 | $10K | — | Filing → |
| ADAP | SELL | 2023-01-17 | $4K | — | Filing → |